Postbiotics for weight loss in advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a treatment called postbiotics (which are helpful byproducts from good bacteria) to see if they can help reduce weight loss and muscle wasting in people with advanced lung cancer. If you have this type of cancer and have been losing weight, this study might offer a way to help you feel stronger and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and have non-small cell lung cancer (a common type of lung cancer) that has spread, often called stage III or IV.
- You should have lost more than 5% of your body weight in the last 6 months without trying, or have a low body mass index (BMI) with some weight loss.
- You should be able to walk and manage daily activities, even if you need some help (your doctor will check this).
- Your liver, kidneys, and heart must be working well enough, as shown by blood tests and a heart check.
- You must not have any other reason for weight loss, not be on a feeding tube, and not be taking certain appetite stimulants or antibiotics recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests a new drug called GB18 to help cancer patients who have experienced significant weight loss and muscle wasting—a condition called cancer cachexia. The drug works by targeting a specific protein involved in weight loss, and researchers want to learn if it can help patients regain weight and strength while also being safe.
This trial tests whether transplanting healthy gut bacteria (called a fecal microbiota transplant, or FMT) can help people with advanced cancer who are losing weight and muscle. The goal is to see if it improves appetite and helps you maintain strength.
This trial tests a new drug, ASCA101, for people with certain cancers who are experiencing unwanted weight loss (cachexia). It aims to see if the drug can help improve appetite and stabilize weight. Participants must have colorectal, ovarian, or lung cancer and meet specific weight loss criteria.
This trial tests whether a nutritional drink with L-carnitine can help people with lung cancer who are losing weight (cachexia) gain or maintain weight while on chemotherapy. L-carnitine may help the body use food better and reduce muscle loss.
This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.
This study looks at how weight loss and muscle loss affect people with advanced cancer. It aims to find different types of weight loss to better guide treatment and care.
Hear when a new Cachexia; Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.